Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Free Report) had its price objective cut by Piper Sandler from $250.00 to $230.00 in a report published on Friday, Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. Several other brokerages have also recently weighed in on PODD. Morgan Stanley raised Insulet from an equal weight […]
Numerai GP LLC trimmed its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 36.4% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 19,156 shares of the medical instruments supplier’s stock after selling 10,960 shares during the quarter. Numerai GP LLC’s holdings […]
Rafferty Asset Management LLC lifted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 8.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 7,282 shares of the medical instruments supplier’s stock after purchasing an additional 562 shares during the quarter. Rafferty Asset Management LLC’s holdings in Insulet were worth $1,161,000 […]
Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $197.14, but opened at $184.93. Insulet shares last traded at $189.01, with a volume of 322,184 shares changing hands. Wall Street Analysts Forecast Growth PODD has been the topic of several […]
Insulet (NASDAQ:PODD – Get Free Report) announced its quarterly earnings results on Thursday. The medical instruments supplier reported $1.40 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.73, Briefing.com reports. The company had revenue of $509.80 million during the quarter, compared to the consensus estimate of $461.26 million. Insulet had […]